Intervention

Sugar pill

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions9

Lead sponsors shown7

Clinical trials

7 shown

Probiotic Use in Patients With Prior COPD ExacerbationNCT02185092 · 2014-10-01

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal ActivityNCT02118610 · 2014-09-01

Effects of Su-Huang Antitussive Capsule on Cough Variant AsthmaNCT01584804 · 2012-06-01

African American Children, Glycemic Control, and Type 2 DiabetesNCT01325987 · 2011-03-01

Varenicline for Gait and Balance Impairment in Parkinson DiseaseNCT01341080 · 2010-12-28

Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive DisorderNCT01168674 · 2010-02-01

Moderate to Persistent Asthma in the Obese SubjectNCT01016847 · 2010-01-01

Common conditions

Asthma2 Bipolar Disorder1 COPD1 Depression1 Obstructive Lung Disease1 Parkinson Disease1 Schizophrenia1 Type 2 Diabetes1 Vitamin D Deficiency1

Leading sponsors

Duke University1 Rush University Medical Center1 The First Affiliated Hospital of Guangzhou Medical University1 Tufts Medical Center1 University of Alabama at Birmingham1 University of Maryland, Baltimore1 University of Oklahoma1

Trial status mix

COMPLETED4

TERMINATED1

UNKNOWN1

WITHDRAWN1

Phase mix

NA3

PHASE43

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.